A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults
Titel:
A phase 3, randomized, active-controlled study to assess the safety and tolerability of meningococcal serogroup B vaccine bivalent rLP2086 in healthy adolescents and young adults
Auteur:
Ostergaard, Lars Lucksinger, Gregg H. Absalon, Judith Beeslaar, Johannes Eiden, Joseph Jansen, Kathrin U. York, Laura J. Quinn, Angela Graversen, Mette E. Perez, John L.